WE HAVE YOUR BACK
YOU ARE INVITED
SERVING OUR FIRST RESPONDERS AS THEY SERVE US.
Join our groundbreaking clinical trial to investigate immune support against COVID-19.
INNOVATION ON THE FRONTLINES
This Phase II clinical trial is specifically designed for those who are regularly exposed to COVID-19 and therefore at the highest risk for contracting the virus. We are investigating whether receiving stem cells prophylactically will provide immune support against the virus. We will monitor outcomes through blood markers.
All processing for stem cell banking as well as therapeutic manufacturing takes place in ISO 7 and 8 cleanrooms designed, certified and monitored in accordance with ISO 14644-1 & 14644-2 standards. All procedures are performed in compliance with cGMP/cGLP regulations. To ensure consistency, we have established a quality management system in accordance with ISO 9001:2015. All of the products we make are proudly made in at our headquarters in Sugar Land, Texas.
Thank you for the opportunity to be a part of this trial and to use stem cells.
Michael, Police Officer
We've had to take extra precautions when dealing with the public, just to be able to protect everybody.
John, Police Officer
I take all these precautions but we're around so many people at work. This is so exciting and from what I've read, this is the future.
Frequently asked questions
Hope Biosciences is a clinical stage biotechnology company focused on developing cell-based therapeutics for acute and chronic disease. During this pandemic, there are currently no approved therapies available to support immunity against the Coronavirus disease.
Hope Biosciences' patented core technology delivers high-quality, fully characterized, fresh mesenchymal stem cells (MSCs), on-demand. MSCs are well-known for their immunomodulatory and regenerative potential.
It is our expectation that providing this therapy will boost the immune system, espeically in cases of individuals at high-risk of developing COVID-19. A healthy immune system is better able to defend against infectious agents like SARS-CoV-2 and decreases the chance a patient will become critically ill. This not only helps keep people healthy, but it decreases the tremendous burden already on a stressed healthcare system. With this treatment, we hope to build a line of defense for our most vulnerable.
SECURE YOUR PLACE
IN OUR LANDMARK CLINICAL TRIAL
No cost to participate.